Abstract: A device for burning, utilizing and enhancing the therapeutic effect of moxa, comprising a cover, a base and a moxa container. The cover is shaped like an upside-down bowl with an opening on its top center. The cover is disposed on the base and has an opening on its top to receive and engage with the moxa container. The base has three legs which stabilize the moxibustion device on human body. The container has a plunger which has an enlarged end and a head to press the moxa contained therewithin together so as to increase its therapeutic effectiveness.

Abstract: A novel method of oxygenating the tissue of a living mammal is disclosed comprising the steps of providing an oxygenated fluorocarbon-containing liquid; injecting that oxygenated liquid into the peritoneal cavity of said mammal; and withdrawing said fluorocarbon liquid from said cavity, said injecting and withdrawing be conducted at a rate sufficient to oxygenate said tissue. Accordingly, a novel "artificial lung" is disclosed which is useful to selectively oxygenate the body of a mammal, as reflected by increased arterial blood gas (pO.sub.2) in said mammal.

Abstract: The hitherto known indirect moxing instruments are relatively difficult to handle, so that they are frequently not used. This problem is eliminated by the present invention, which provides an instrument which can be easily and rapidly applied by self-therapy to even difficultly reachable points of the body and which ensures optimum effectiveness. Reference is made to the main claim and FIG. 1.

Abstract: A single casing houses first and second blowers for expelling air through first and second outlet passages. One of the outlet passages incorporates a heater so that hot air can be expelled. The other passage is free of any heater so that cool air is expelled from the second passage. By alternately actuating the blowers, a person can be treated to hot air and then cool air.

Abstract: A novel acute care cerebral support system and method for treating severly ischemic brains is disclosed wherein an oxygenated nutrient emulsion is circulated through at least a portion of the ventriculo-subarachnoid spaces. The nutrient emulsion contains an oxygenatable non-aqueous component, an aqueous nutrient component, an emulsification component, and other components which render physiologic acceptability to the nutrient emulsion. The disclosed system and method have been shown to effectively exchange oxygen, carbon dioxide, glucose, and other metabolites in severely stroked brains. Significant restoration of oxidative metabolism and electrographic activity result from the disclosed treatment. Methods for producing the nutrient emulsion and a system for delivering that emulsion to the cerebrospinal pathway are also disclosed. Additionally, novel diagnostic methods for diagnosing the physiologic state of hypoxic-ischemic and other diseased neurologic tissue during treatment are provided.

Abstract: Baby chicks are loaded in an open top container 32 and the container is moved into an open ended cabinet 18. In response to the movement of the container into the cabinet, a dose of vaccine is emitted through at least one nozzle 42 supported in the upper portion of the cabinet. The spray emitted from the nozzle is of a droplet size large enough to fall onto the chicks in the container substantially without remaining airborne long enough to be inhaled by the chicks.

Abstract: A novel system and method for treating ischemic neurologic tissue is disclosed wherein an oxygenated nutrient emulsion is circulated through at least a portion of the cerebospinal pathway. The nutrient emulsion contains an oxygenatable non-aqueous component, an aqueous nutrient component, an emulsification component, and other components which render physiologic acceptability of the nutrient emulsion. Methods for producing the nutrient emulsion and a system for delivering that emulsion to the cerebrospinal pathway are also disclosed. Additionally, novel diagnostic methods for diagnosing the physiologic state of hypoxic-ischemic and other diseased neurologic tissue during treatment are provided.